Infigratinib in Subjects with Gastric or gastroesophageal junction Cancer with FGFR2 Amplification or Other Solid Tumors with Other FGFR Genetic Alterations(LB1001-201 study) Metabolome Data
Title | Infigratinib in Subjects with Gastric or gastroesophageal junction Cancer with FGFR2 Amplification or Other Solid Tumors with Other FGFR Genetic Alterations(LB1001-201 study) Metabolome Data |
---|---|
Description | Metabolome pharmacokinetics |
Organism | Homo sapiens |
Data Type | Other Type of Metabolome Data |
Data Accessibility | Controlled-access |
BioProject | PRJCA017207 |
Release Date | 2023-10-24 |
Submitter | lin shen (linshenpku@163.com) |
Organization | Beijing Cancer Hospital |
Submission Date | 2023-05-24 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
---|---|---|---|---|---|---|---|
OMIX004141-01 | Metabolome pharmacokinetics | 1 | Other Type of Metabolome Data | 12.9 MB | xlsx | 0 | Controlled |